Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 81,708
Avg Vol 165,309
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 26%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell programming in the United States. It operates through Cell Engineering and Biosecurity segments. The company offers cell engineering research and development solutions, as well as cell engineering tools comprising functional genomics and antibody developability Datapoints services, artificial intelligence models, and reconfigurable automation cart systems on its platform for use in the research, developm...

Industry: Biotechnology
Sector: Healthcare
Phone: 877 422 5362
Address:
27 Drydock Avenue, 8th Floor, Boston, United States
Latest News on DNABW
No data available.